FDA warns against using asthma drug terbutaline to delay premature births – Los Angeles Times


Consumer Affairs

FDA warns against using asthma drug terbutaline to delay premature births
Los Angeles Times
Terbutaline, commercially marketed as Brethine and Bricanyl, is a drug approved for the treatment of asthma and chronic obstructive pulmonary disorder, sometimes called emphysema. It relaxes bronchial tubes and is used to ease asthma symptoms.
FDA Issues Warning on Asthma Drug in Preterm LaborMedPage Today
Asthma drug not safe for obstetric useClinical Advisor
FDA Warns Against Certain Uses of Asthma Drug Terbutaline for Preterm LaborPR Newswire (press release)
Bioscience Technology –Medscape
all 25 news articles »

View full post on asthma – Google News

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.